350 related articles for article (PubMed ID: 26544630)
1. Analogues of ethionamide, a drug used for multidrug-resistant tuberculosis, exhibit potent inhibition of tyrosinase.
Choi J; Park SJ; Jee JG
Eur J Med Chem; 2015 Dec; 106():157-66. PubMed ID: 26544630
[TBL] [Abstract][Full Text] [Related]
2. Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors.
Choi J; Jee JG
Int J Mol Sci; 2015 Dec; 16(12):28534-48. PubMed ID: 26633377
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents.
Raghu MS; Pradeep Kumar CB; Yogesh Kumar K; Prashanth MK; Alshahrani MY; Ahmad I; Jain R
Bioorg Med Chem Lett; 2022 Mar; 60():128604. PubMed ID: 35123004
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of the antituberculosis drug ethionamide.
Vale N; Gomes P; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):151-8. PubMed ID: 23215813
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine Drugs Repositioned as Tyrosinase Inhibitors.
Choi J; Lee YM; Jee JG
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283382
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis of Cinnamyl-paeonol derivatives with 1, 3-Dioxypropyl as link arm and screening of tyrosinase inhibition activity in vitro.
Tang K; Jiang Y; Zhang H; Huang W; Xie Y; Deng C; Xu H; Song X; Xu H
Bioorg Chem; 2021 Jan; 106():104512. PubMed ID: 33293056
[TBL] [Abstract][Full Text] [Related]
7. Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosis.
Prieri M; Frita R; Probst N; Sournia-Saquet A; Bourotte M; Déprez B; Baulard AR; Willand N
Eur J Med Chem; 2018 Nov; 159():35-46. PubMed ID: 30268015
[TBL] [Abstract][Full Text] [Related]
8. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
[TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of ethionamide-mesoporous silicon nanoparticles against Mycobacterium tuberculosis.
Vale N; Correia A; Silva S; Figueiredo P; Mäkilä E; Salonen J; Hirvonen J; Pedrosa J; Santos HA; Fraga A
Bioorg Med Chem Lett; 2017 Feb; 27(3):403-405. PubMed ID: 28057421
[TBL] [Abstract][Full Text] [Related]
10. Development of potent chemical antituberculosis agents targeting Mycobacterium tuberculosis acetohydroxyacid synthase.
Jung IP; Ha NR; Lee SC; Ryoo SW; Yoon MY
Int J Antimicrob Agents; 2016 Sep; 48(3):247-58. PubMed ID: 27451857
[TBL] [Abstract][Full Text] [Related]
11. Structural and docking studies of potent ethionamide boosters.
Tatum NJ; Villemagne B; Willand N; Deprez B; Liebeschuetz JW; Baulard AR; Pohl E
Acta Crystallogr C; 2013 Nov; 69(Pt 11):1243-50. PubMed ID: 24192167
[TBL] [Abstract][Full Text] [Related]
12. Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues.
Ullah S; Park C; Ikram M; Kang D; Lee S; Yang J; Park Y; Yoon S; Chun P; Moon HR
Bioorg Chem; 2019 Jun; 87():43-55. PubMed ID: 30856375
[TBL] [Abstract][Full Text] [Related]
13. Ensemble-Based Virtual Screening Led to the Discovery of New Classes of Potent Tyrosinase Inhibitors.
Choi J; Choi KE; Park SJ; Kim SY; Jee JG
J Chem Inf Model; 2016 Feb; 56(2):354-67. PubMed ID: 26750991
[TBL] [Abstract][Full Text] [Related]
14. Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.
Flipo M; Desroses M; Lecat-Guillet N; Dirié B; Carette X; Leroux F; Piveteau C; Demirkaya F; Lens Z; Rucktooa P; Villeret V; Christophe T; Jeon HK; Locht C; Brodin P; Déprez B; Baulard AR; Willand N
J Med Chem; 2011 Apr; 54(8):2994-3010. PubMed ID: 21417236
[TBL] [Abstract][Full Text] [Related]
15. Effect of p-aminophenols on tyrosinase activity.
Komori Y; Imai M; Yamauchi T; Higashiyama K; Takahashi N
Bioorg Med Chem; 2014 Aug; 22(15):3994-4000. PubMed ID: 24972725
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.
Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):874-83. PubMed ID: 25643758
[TBL] [Abstract][Full Text] [Related]
19. Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking.
Tan X; Song YH; Park C; Lee KW; Kim JY; Kim DW; Kim KD; Lee KW; Curtis-Long MJ; Park KH
Bioorg Med Chem; 2016 Jan; 24(2):153-9. PubMed ID: 26706112
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel azo-resveratrol, azo-oxyresveratrol and their derivatives as potent tyrosinase inhibitors.
Song YM; Ha YM; Kim JA; Chung KW; Uehara Y; Lee KJ; Chun P; Byun Y; Chung HY; Moon HR
Bioorg Med Chem Lett; 2012 Dec; 22(24):7451-5. PubMed ID: 23142612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
